Pancreatic Cancer Research

ResearcherNew York UniversityNo recent work listed

Fei Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1206-9684; OpenAlex author ID A5100325793. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: 1 paper

Papers 2

  1. RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer. Co-author DOI 10.1016/j.ccell.2018.10.006↗
  2. Elevated DNA damage response in pancreatic cancer. Last author DOI 10.1007/s00418-014-1245-7↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Deirdre Jill Cohen · 1 shared paper, 2018 · strength 0.05
  2. Emma Kurz · 1 shared paper, 2018 · strength 0.05
  3. Berk Aykut · 1 shared paper, 2018 · strength 0.05
  4. Philip A. Harris · 1 shared paper, 2018 · strength 0.05
  5. Wei Wang · 1 shared paper, 2018 · strength 0.05
  6. Atsuo Ochi · 1 shared paper, 2018 · strength 0.05
  7. Joshua Leinwand · 1 shared paper, 2018 · strength 0.05
  8. George Miller · 1 shared paper, 2018 · strength 0.05
  9. Xiaochun Yu · 1 shared paper, 2014 · strength 0.04
  10. Mo Li · 1 shared paper, 2014 · strength 0.04
  11. Michael D. Osterman · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.